Explanation of the guideline on diagnosis and management of chronic hepatitis B in children,young people and adults updated by NICE in 2013

ZHUANG Hui
DOI: https://doi.org/10.16505/j.2095-0136.2013.06.008
2013-01-01
Abstract:The guideline on diagnosis and management of chronic hepatitis B in children,young people and adults issued by the National Institute for Health and Care Excellence(NICE),the United Kingdom in June 2013updates and replaces recommendations in NICE technology appraisal 96and incorporates recommenda- tions from NICE technology appraisals 96,153,154and 173.This guideline covers the following:informa- tion needs of people with chronic hepatitis B and their carers;where children,young people and adults with chronic hepatitis B should be assessed;assessment of liver disease,including the use of non-invasive tests and genotype testing;criteria for offering antiviral treatment;the efficacy,safety and cost;effectiveness of cur- rently available treatments;selection of first-line therapy;management of treatment failure or drug resistance; whether there is a role for combination therapy;when it is possible to stop treatment;managing the care of pregnant and breastfeeding women and prevention of vertical transmission;prophylactic treatment during im- munosuppressive therapy;monitoring for treatment response,severity of fibrosis and development of HCC.
What problem does this paper attempt to address?